Sugi Predict

Sugi Predict / Targets / NUDT21

NUDT21

Cleavage and polyadenylation specificity factor subunit 5 · O43809 · NUDT21 on Sugi Atlas →

0 patent compounds predicted against NUDT21, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NUDT21 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
The Effectiveness of Kuvan in Amish PKU Patients PHASE4COMPLETED
COMPARING TWO PROTOCOLS FOR FINAL OOCYTE MATURATION IN POOR RESPONDERS UNDERGOING GnRH-ANTAGONIST ICSI CYCLES PHASE3UNKNOWN
Reverse Transcriptase Inhibitors in AGS PHASE2COMPLETED
Clinical Study of EBV-LMP1 Targeted DNAzyme to Treat Nasopharyngeal Carcinoma PHASE1/PHASE2COMPLETED
Pharmacogenetics of Disulfiram for Cocaine PHASE2COMPLETED
Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid Tumors PHASE1COMPLETED
A Phase I Trial of SHR3162 in Subjects With Advanced Solid Tumors PHASE1COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
Study of Constitutional Platelet Disease nanUNKNOWN
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Circulating Markers for Ischemic Heart Disease nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
miR-155 Expression in Episodic and Chronic Migraine nanUNKNOWN
Thoracic Aortic Dilatation Syndromes nanCOMPLETED
Identification of Viable Human Embryos Using Three Different Methods nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
miRNA as a Growth Plate Marker After GH nanUNKNOWN
Genetic Screening and Assisted Oocyte Activation in Couples with Diminished/aberrant Embryonic Development. nanCOMPLETED
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure nanRECRUITING
Prospective Identification of Long QT Syndrome in Fetal Life nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Diagnosis of RSTS: Identification of the Acetylation Profiles as Epigenetic Markers for Assessing Causality of CREBBP and EP300 Variants. nanUNKNOWN
Immunophenotyping and Xist Gene in AML nanUNKNOWN
Transcripts with Retained H/ACA Box SnoRNA Sequences As Biomarkers for Estrogen Dependence in Lum-B Breast Carcinomas nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a NUDT21 binder may also engage these)

ProteinNameSimilarity
Q9CQF3 — 1.000 Q9CQF3 →
Q6DJE4 — 1.000 Q6DJE4 →
Q5RAI8 — 1.000 Q5RAI8 →
Q3ZCA2 — 1.000 Q3ZCA2 →
Q4KM65 — 1.000 Q4KM65 →
Q7T3C6 — 0.999 Q7T3C6 →
Q94AF0 — 0.989 Q94AF0 →
Q8GXS3 — 0.989 Q8GXS3 →
Q55E68 — 0.985 Q55E68 →
Q8WSR4 — 0.973 Q8WSR4 →
Q7SH49 — 0.972 Q7SH49 →
G5EF51 — 0.972 G5EF51 →
A1DFN6 — 0.971 A1DFN6 →
Q5XHF8 — 0.971 Q5XHF8 →
B1AY13 — 0.971 B1AY13 →
Q9D2K4 — 0.971 Q9D2K4 →
Q91YN0 — 0.970 Q91YN0 →
Q8VDY4 — 0.970 Q8VDY4 →
P60670 — 0.970 P60670 →
Q6PJI9 — 0.970 Q6PJI9 →
Q568Q0 — 0.970 Q568Q0 →
Q008S8 — 0.970 Q008S8 →
Q9EPN1 — 0.970 Q9EPN1 →
Q21029 — 0.970 Q21029 →
Q8C0M0 — 0.970 Q8C0M0 →
Q6P1Y8 — 0.970 Q6P1Y8 →
Q9ESE1 — 0.970 Q9ESE1 →
Q3V3E1 — 0.970 Q3V3E1 →
Q6P5D8 — 0.970 Q6P5D8 →
E0W1I1 — 0.969 E0W1I1 →